Mycrodose Therapeutics Granted DEA and FDA Approval to Cultivate Psilocybin Mushrooms in the United States

DEA approval allows Mycrodose Therapeutics to become the first vertically integrated US Pharmaceutical company utilizing psilocybin-based psychedelic medicine. Approval also allows Mycrodose the ability

Related Keywords

California ,United States ,San Diego ,Kostenloser Wertpapierhandel ,Patrick Eckstrom ,Psilocybe Cubensis ,Frank Kochinke ,Drug Administration ,Microdosing Technology ,Us Drug Enforcement Agency ,Mycrodose Therapeutics Inc ,California Newsfile Corp ,Mycrodose Scientific Team ,Schedulei Research ,Mycrodose Therapeutics ,Intellectual Property ,Enforcement Agency ,Chad Conner ,Chief Executive Officer ,Scientific Team ,Chief Scientific Officer ,Protected Sustained Microdosing Technology ,Mycrodose ,Herapeutics ,Granted ,Approval ,Cultivate ,Silocybin ,Mushrooms ,United ,States ,